Banco Santander’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,025
| Closed | -$183K | – | 428 |
|
|
2024
Q1 | $183K | Sell |
4,025
-2,263
| -36% | -$103K | ﹤0.01% | 407 |
|
|
2023
Q4 | $291K | Buy |
6,288
+545
| +9% | +$25.2K | ﹤0.01% | 382 |
|
|
2023
Q3 | $234K | Sell |
5,743
-45
| -0.8% | -$1.83K | ﹤0.01% | 407 |
|
|
2023
Q2 | $281K | Hold |
5,788
| – | – | ﹤0.01% | 387 |
|
|
2023
Q1 | $285K | Sell |
5,788
-762
| -12% | -$37.5K | ﹤0.01% | 338 |
|
|
2022
Q4 | $331K | Sell |
6,550
-400
| -6% | -$20.2K | ﹤0.01% | 331 |
|
|
2022
Q3 | $349K | Sell |
6,950
-3,958
| -36% | -$199K | ﹤0.01% | 328 |
|
|
2022
Q2 | $533K | Sell |
10,908
-3,537
| -24% | -$173K | 0.01% | 323 |
|
|
2022
Q1 | $868K | Sell |
14,445
-6,793
| -32% | -$408K | 0.01% | 319 |
|
|
2021
Q4 | $1.69M | Buy |
21,238
+8,970
| +73% | +$712K | 0.01% | 257 |
|
|
2021
Q3 | $1.09M | Buy |
+12,268
| New | +$1.09M | 0.01% | 286 |
|